New year, new EANM Board composition! Check out who, as of January 01, 2023, will serve on the board.
The first paper to define the workflow for the use of biomarkers in the etiological diagnosis of neurocognitive disorders in MCI and mild dementia stages has been published! Find out more.
The third issue has been released! Read more here and browse through this new edition on policy updates within nuclear medicine.
EANM President, Jolanta Kunikowska, would like to keep you updated on recent developments and sends her greetings your way. Read her newsletter here!